Friday, April 02, 2021 9:53:32 AM
And that being said, with everything positive Elite has going on and I mean everything is pointing in the right direction now. I mean you’ve covered the debt issues, the bonds and everything and the ART products moving forward, I mean we are as positive as I had ever seen it. The independent valuation of the company put the stock price at a median of $2.10 a share with a high of $2.75 based on the current generic line which is even ever increasing right now with the Mikah products. Why do you guys think we are stuck in this penny land right now as supposed to dollar land?
Nasrat Hakim
Very good question and if you figure out why please let me know. There are a lot of factors for that. We're talking about historically Elite did not perform on a technology they’ve had for over 10 years. So some of the stockholders have gone a little shy. Me personally before I even joined the company from day one I told you all in my very first meeting when the stock was only $0.07 or $0.068, if we were an R&D company with what I’ve seen today the stock should jump tenfold, ten times and I still stand by that. I think we have a great company, I think our stock is undervalued but maybe I am biased because I see exactly what we have and I see the potential for the market. I see what the Congress is asking for, I see what the [ST] is asking for, and I see the number of dollars that are associated with this segment that we are in or a part of. There is a lot of money to be made in the future and when people see that I think the stock price is going to adjust accordingly.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM